Erratum: Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women (The American Journal of Clinical Nutrition (2010) 92(5) (1251–1256), (S0002916523129352), (10.3945/ajcn.2010.29371));Multivitamin use and the risk of myocardial infarction: A population-based cohort of Swedish women

American Journal of Clinical Nutrition

Volumn 92, Issue 5, 2010, Pages 1251-1256

  Rautiainen, Susanne ^a   Åkesson, Agneta ^a   Levitan, Emily B ^b   Morgenstern, Ralf ^a   Mittleman, Murray A ^c   Wolk, Alicja ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; VITAMIN D; VITAMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROSPECTIVE STUDY; QUESTIONNAIRE; SWEDEN; VITAMIN SUPPLEMENTATION; WOMEN'S HEALTH; HEALTH CARE POLICY; MIDDLE AGED; RISK FACTOR;

AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; NUTRITION POLICY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SWEDEN; VITAMINS;

EID: 78149241447     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.009696     Document Type: Erratum

References (41)

1. Messerer M, Johansson SE, Wolk A. Use of dietary supplements and natural remedies increased dramatically during the 1990s. J Intern Med 2001;250:160-6. (Pubitemid 32868696)
2. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 2004;104:942-50.
3. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004;160:339-49. (Pubitemid 39045265)
4. Neuhouser ML, Patterson RE, Levy L. Motivations for using vitamin and mineral supplements. J Am Diet Assoc 1999;99:851-4.
5. Thomson MJ, Puntmann V, Kaski JC. Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment? Cardiovasc Drugs Ther 2007;21:195-210.
6. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA 2002;287:3116-26.
7. McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008;99(suppl 3):S48-54.
8. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008;19:50-6.
9. Brigelius-Flohe R, Banning A, Schnurr K. Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 2003;5:205-15.
10. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42.
11. Holmquist C, Larsson S, Wolk A, de Faire U. Multivitamin supplements are inversely associated with risk of myocardial infarction in men and women - Stockholm Heart Epidemiology Program (SHEEP). J Nutr 2003;133:2650-4.
12. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:261-6. (Pubitemid 29065549)
13. Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-64.
14. Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr. Multivitamin use and mortality in a large prospective study. Am J Epidemiol 2000;152:149-62.
15. Pocobelli G, Peters U, Kristal AR, White E. Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol 2009;170:472-83.
16. Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009;169:294-304.
17. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 2002;162:1472-6.
18. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008;CD007176.
19. Wolk A, Bergstrom R, Hunter D, et al. A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med 1998;158:41-5.
20. Wolk A, Larsson SC, Johansson JE, Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA 2006;296:1371-6.
21. Messerer M, Johansson SE, Wolk A. The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr 2004;134:1800-5.
22. Messerer M, Wolk A. Sensitivity and specificity of self-reported use of dietary supplements. Eur J Clin Nutr 2004;58:1669-71. (Pubitemid 40028531)
23. Michels KB, Wolk A. A prospective study of variety of healthy foods and mortality in women. Int J Epidemiol 2002;31:847-54.
24. Norman A, Bellocco R, Bergstrom A, Wolk A. Validity and reproducibility of self-reported total physical activity - differences by relative weight. Int J Obes Relat Metab Disord 2001;25:682-8.
25. Socialstyrelsen. Svensk version av ICD-10 [Swedish Board of Health and Welfare (Swedish version of ICD-10)]. Available from: http://www. socialstyrelsen.se/klassificeringochkoder/sokdiagnoskodicd-10?search= I00-I99#listing (cited 16 September 2010) (in Swedish).
26. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001;30(suppl 1): S30-4.
27. Cox D. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
28. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:56-70.
29. US Preventive Services Task Force.. Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale. Ann Intern Med 2003;139:51-5.
30. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2009;CD006612.
31. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008;300:2123-33.
32. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65.
33. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47.
34. Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007;167:1610-8.
35. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:154-60.
36. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-20.
37. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
38. McCully KS. Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr 2007;86(suppl):1563S-8S.
39. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 2009;30:6-15.
40. Livsmedelsverkets Föreskrifter om Berikning av Vissa Livsmedel: SLVFS 1983 [Swedish National Food Administration]. Available from: http://www.slv.se/upload/dokument/lagstiftning/1980-talet/1983-02.pdf (cited 5 May 2010) (in Swedish).
41. Europaparlaments och Rådets Förordning (EG) nr 1925/2006 av den 20 december 2006 om Tillsättning av Vitaminer och Mineralämnen samt Vissa Andra Ä mnen i Livsmedel [EC Regulation no. 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the Addition of Vitamins and Minerals and of Certain Other Substances to Foods]. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2006R1925: 20080304:SV:PDF (cited 10 May 2010) (in Swedish).